Full history for every metric is available with a Kvantra account
The Oncology Institute, Inc. (TOI)
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 188 | 203 | 252 | 324 | 393 | 503 | 587 |
| Operating profit | $m | -36 | -26 | |||||
| Net profit | $m | -14 | -11 | 0 | -83 | -65 | -61 | -36 |
| EPS reported | $ | -0.54 | -0.28 | |||||
| Operating cashflow per share | $ | -0.03 | 0.00 | |||||
| Capex per share | $ | 0.00 | 0.00 | |||||
| FCF per share | $ | -0.03 | -0.00 | |||||
| Free cash flow | $m | -28 | -3 | |||||
| Net debt | $m | 44 | -41 | |||||
| Book value equity | $m | -16 | -25 | |||||
| Book value per share | $ | -0.02 | -0.02 | |||||
| Number of shares | m | 923.89 | 1,030.31 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -209.23 | -20.59 | |||||
| P/S LTM | x | 6.54 | 0.87 | |||||
| P/FCF LTM | x | -118.37 | -156.09 | |||||
| EV/EBITDA LTM | x | -79.01 | -25.45 | |||||
| EV/Sales LTM | x | 6.68 | 0.80 | |||||
| Earnings Yield LTM | % | -1.84% | -0.69% | |||||
| FCF Yield | % | -0.84% | -0.64% | |||||
| Quality | ||||||||
| ROE | % | 385.53% | 209.81% | |||||
| ROIC | % | -35.70% | -28.82% | |||||
| Operating margin | % | -7.18% | -4.44% | |||||
| Gross margin | % | 15.20% | 10.79% | |||||
| FCF/Sales | % | -5.53% | -0.56% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +27.79% | +38.38% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.27 | -0.13 | |||||
| Net Debt/EBITDA | x | -1.65 | 0.89 | |||||
| EBIT/Net interest | x | -3.20 | -3.42 | |||||
| Net debt/market cap | % | 1.33% | -8.01% | |||||
| Net debt/Equity | x | -2.79 | 1.65 | |||||
| Gross debt/equity | x | -6.60 | -0.99 | |||||
Company overview
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
The Oncology Institute, Inc. (TOI)
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free